1-7 of 7
Christopher D. Gocke
Close
Sort by
Journal Articles

Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies

Philip H. Imus, Sergiu Pasca, Hua-Ling Tsai, Yosra M. Aljawai, Kenneth R. Cooke, Jeremy D. Walston, Christopher D. Gocke, Ravi Varadhan, Richard J. Jones, Lukasz P. Gondek
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3849–3858.
https://doi.org/10.1182/bloodadvances.2023011761
Published: 2024
Includes: Supplemental data
Journal Articles

The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts

In Young Choi, Jonathan P Ling, Jian Zhang, Eric Helmenstine, Wencke Walter, Panagiotis Tsakiroglou, Riley E Bergman, Céline Philippe, James L Manley, Kevin Rouault-Pierre, Bing Li, Daniel Howard Wiseman, Kiran Batta, Madhu M Ouseph, Elsa Bernard, Benjamin Dubner, Xiao Li, Torsten Haferlach, Anna Koget, Salman Fazal, Tania Jain, Christopher D. Gocke, Amy E DeZern, William Brian Dalton
Journal: Blood Advances
Blood Adv bloodadvances.2023011260.
https://doi.org/10.1182/bloodadvances.2023011260
Published: 2024
Includes: Supplemental data
Journal Articles

Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes

Sergiu Pasca, Matthew Z. Guo, Shiyu Wang, Kristin Stokvis, Audra Shedeck, Aparna Pallavajjala, Cynthia Shams, Roshni Pallavajjala, Amy E. DeZern, Ravi Varadhan, Christopher D. Gocke, Richard J. Jones, Lukasz P. Gondek
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4660–4670.
https://doi.org/10.1182/bloodadvances.2023010416
Published: 2023
Includes: Supplemental data
Journal Articles

Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report

Thomas D. Lee, Dara L. Aisner, Marjorie P. David, Celeste C. Eno, Jeffrey Gagan, Christopher D. Gocke, Natalya V. Guseva, Lisa Haley, Audrey N. Jajosky, Daniel Jones, Mahesh M. Mansukhani, Pawel Mroz, Sarah S. Murray, Kimberly J. Newsom, Vera Paulson, Somak Roy, Chase Rushton, Jeremy P. Segal, T. Niroshini Senaratne, Alexa J. Siddon, Petr Starostik, Jessica A. G. Van Ziffle, David Wu, Rena R. Xian, Sophia Yohe, Annette S. Kim
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4599–4607.
https://doi.org/10.1182/bloodadvances.2023010149
Published: 2023
Includes: Supplemental data
Journal Articles

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden

Clinical Trials & Observations
Theodoros Karantanos, Shruti Chaturvedi, Evan M. Braunstein, Jerry Spivak, Linda Resar, Styliani Karanika, Donna M. Williams, Ophelia Rogers, Christopher D. Gocke, Alison R. Moliterno
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2567–2576.
https://doi.org/10.1182/bloodadvances.2019001407
Published: 2020
Includes: Supplemental data
Journal Articles

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing

W. Brian Dalton, Eric Helmenstine, Lisa Pieterse, Bing Li, Christopher D. Gocke, Joshua Donaldson, Zhijian Xiao, Lukasz P. Gondek, Gabriel Ghiaur, Ivana Gojo, B. Douglas Smith, Mark J. Levis, Amy E. DeZern
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1192–1196.
https://doi.org/10.1182/bloodadvances.2019001127
Published: 2020
Includes: Supplemental data
Journal Articles

A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3 -ITD mutations

Clinical Trials & Observations
Mark J. Levis, Alexander E. Perl, Jessica K. Altman, Christopher D. Gocke, Erkut Bahceci, Jason Hill, Chaofeng Liu, Zhiyi Xie, Andrew R. Carson, Valerie McClain, Timothy T. Stenzel, Jeffrey E. Miller
Journal: Blood Advances
Blood Adv (2018) 2 (8): 825–831.
https://doi.org/10.1182/bloodadvances.2018015925
Published: 2018
Includes: Supplemental data